FOMO/HYPING TWITTER
TheLion Stock Trader @TheLioncom
$CAPR Capricor is setting up for huge runs next few days due to a huge DMD event tomorrow (weekend ) as well as management CC next Thurs updating the public on both Capricor’s Covid19 drug data and its vaccine research timeline. Press is coming.
-Ceo linda marban has met with the agency and send a proposal for accelerated approval of cap 1002.
-This ran huge on news at the end of April. Expecting another nice move here... GL!
-setting a $20 PT next week on huge win w/ CAP-1002 DMD drug getting great applause from DMD community this wknd. Super undisputable data stops DMD patients dying cardiac problems as the #1 death rate DMD patients. Also covid19 updates next week.
-Fast track FDA talks to begin according to the event hosted this weekend by the biggest DMD drug advocating community that let Sarepta drug approved by the FDA. $SRPT market cap is now $13 Billion Capricor is merely $110m. The DMD they targeting is in nonambulance setting first.
-There is a SUPER disconnect on Capricor’s $CAPR stock valuation here while other pharma’s Covid19 programs I DD aren’t as good but commands whopping $1B to $3B valuations alone. The market will quickly close this huge gap by valuing Capricor properly.
-How do you know PR is coming next week?
-There is major CC thurs. Next Thursday both the CEO and Chief Research Scientific officer will give updates on Capricor Covid19 drug and vaccine program utilizing the liposome technology which is robust and very safe. The phase 1 compassionate use results in death bed setting saved all lives.
TheLion Stock Trader @TheLioncom
$CAPR Capricor is setting up for huge runs next few days due to a huge DMD event tomorrow (weekend ) as well as management CC next Thurs updating the public on both Capricor’s Covid19 drug data and its vaccine research timeline. Press is coming.
-Ceo linda marban has met with the agency and send a proposal for accelerated approval of cap 1002.
-This ran huge on news at the end of April. Expecting another nice move here... GL!
-setting a $20 PT next week on huge win w/ CAP-1002 DMD drug getting great applause from DMD community this wknd. Super undisputable data stops DMD patients dying cardiac problems as the #1 death rate DMD patients. Also covid19 updates next week.
-Fast track FDA talks to begin according to the event hosted this weekend by the biggest DMD drug advocating community that let Sarepta drug approved by the FDA. $SRPT market cap is now $13 Billion Capricor is merely $110m. The DMD they targeting is in nonambulance setting first.
-There is a SUPER disconnect on Capricor’s $CAPR stock valuation here while other pharma’s Covid19 programs I DD aren’t as good but commands whopping $1B to $3B valuations alone. The market will quickly close this huge gap by valuing Capricor properly.
-How do you know PR is coming next week?
-There is major CC thurs. Next Thursday both the CEO and Chief Research Scientific officer will give updates on Capricor Covid19 drug and vaccine program utilizing the liposome technology which is robust and very safe. The phase 1 compassionate use results in death bed setting saved all lives.